189 related articles for article (PubMed ID: 34300226)
1. Altered Electrical, Biomolecular, and Immunologic Phenotypes in a Novel Patient-Derived Stem Cell Model of Desmoglein-2 Mutant ARVC.
Hawthorne RN; Blazeski A; Lowenthal J; Kannan S; Teuben R; DiSilvestre D; Morrissette-McAlmon J; Saffitz JE; Boheler KR; James CA; Chelko SP; Tomaselli G; Tung L
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300226
[TBL] [Abstract][Full Text] [Related]
2. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein-2 mutations in propeptide cleavage-site causes arrhythmogenic right ventricular cardiomyopathy/dysplasia by impairing extracellular 1-dependent desmosomal interactions upon cellular stress.
Vite A; Gandjbakhch E; Hery T; Fressart V; Gary F; Simon F; Varnous S; Hidden Lucet F; Charron P; Villard E
Europace; 2020 Feb; 22(2):320-329. PubMed ID: 31845994
[TBL] [Abstract][Full Text] [Related]
4. Distal myopathy induced arrhythmogenic right ventricular cardiomyopathy in a pedigree carrying novel DSG2 null variant.
Chen P; Li Z; Yu B; Ma F; Li X; Wang DW
Int J Cardiol; 2020 Jan; 298():25-31. PubMed ID: 31653443
[TBL] [Abstract][Full Text] [Related]
5. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
6. Rare non-coding Desmoglein-2 variant contributes to Arrhythmogenic right ventricular cardiomyopathy.
Christensen AH; Andersen CB; Wassilew K; Svendsen JH; Bundgaard H; Brand SM; Schmitz B
J Mol Cell Cardiol; 2019 Jun; 131():164-170. PubMed ID: 31051180
[TBL] [Abstract][Full Text] [Related]
7. An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.
Chatterjee D; Fatah M; Akdis D; Spears DA; Koopmann TT; Mittal K; Rafiq MA; Cattanach BM; Zhao Q; Healey JS; Ackerman MJ; Bos JM; Sun Y; Maynes JT; Brunckhorst C; Medeiros-Domingo A; Duru F; Saguner AM; Hamilton RM
Eur Heart J; 2018 Nov; 39(44):3932-3944. PubMed ID: 30239670
[TBL] [Abstract][Full Text] [Related]
8. Mutated desmoglein-2 proteins are incorporated into desmosomes and exhibit dominant-negative effects in arrhythmogenic right ventricular cardiomyopathy.
Rasmussen TB; Palmfeldt J; Nissen PH; Magnoni R; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
Hum Mutat; 2013 May; 34(5):697-705. PubMed ID: 23381804
[TBL] [Abstract][Full Text] [Related]
9. Endurance Training Provokes Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Heterozygous Desmoglein-2 Mutants: Alleviation by Preload Reduction.
Fabritz L; Fortmueller L; Gehmlich K; Kant S; Kemper M; Kucerova D; Syeda F; Faber C; Leube RE; Kirchhof P; Krusche CA
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790949
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
[TBL] [Abstract][Full Text] [Related]
11. Mutations of desmoglein-2 in sudden death from arrhythmogenic right ventricular cardiomyopathy and sudden unexplained death.
Zhang M; Xue A; Shen Y; Oliveira JB; Li L; Zhao Z; Burke A
Forensic Sci Int; 2015 Oct; 255():85-8. PubMed ID: 26296472
[TBL] [Abstract][Full Text] [Related]
12. In vitro analysis of arrhythmogenic cardiomyopathy associated desmoglein-2 (DSG2) mutations reveals diverse glycosylation patterns.
Debus JD; Milting H; Brodehl A; Kassner A; Anselmetti D; Gummert J; Gaertner-Rommel A
J Mol Cell Cardiol; 2019 Apr; 129():303-313. PubMed ID: 30885746
[TBL] [Abstract][Full Text] [Related]
13. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
14. Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.
Kant S; Holthöfer B; Magin TM; Krusche CA; Leube RE
Circ Cardiovasc Genet; 2015 Aug; 8(4):553-63. PubMed ID: 26085008
[TBL] [Abstract][Full Text] [Related]
15. Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation.
Lin Y; Huang J; He S; Feng R; Zhong Z; Liu Y; Ye W; Li X; Liao H; Fei H; Rao F; Shan Z; Deng C; Zhan X; Xue Y; Liu H; Zhang B; Wang K; Zhang Q; Wu S; Lin X
BMC Med Genet; 2018 Aug; 19(1):148. PubMed ID: 30129429
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy.
Fu M; Hua X; Shu S; Xu X; Zhang H; Peng Z; Mo H; Liu Y; Chen X; Yang Y; Zhang N; Wang X; Liu Z; Yue G; Hu S; Song J
BMC Med; 2024 Jan; 22(1):11. PubMed ID: 38185631
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Probably Caused by DSG2 p.Val149Ile Mutation as Genetic Background When Carrying with Heterozygous PRRT2 p.Arg217ProfsTer8 Mutation: A Case Report.
Huang R; Luo Y; Zhao J; Su K; Lei Y; Li Y
Int Med Case Rep J; 2021; 14():307-313. PubMed ID: 34012299
[TBL] [Abstract][Full Text] [Related]
18. Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2.
Qadri S; Anttonen O; Viikilä J; Seppälä EH; Myllykangas S; Alastalo TP; Holmström M; Heliö T; Koskenvuo JW
BMC Med Genet; 2017 Aug; 18(1):86. PubMed ID: 28818065
[TBL] [Abstract][Full Text] [Related]
19. Sudden death during exercise in a juvenile with arrhythmogenic right ventricular cardiomyopathy and desmoglein-2 gene substitution: a case report.
Sato T; Nishio H; Suzuki K
Leg Med (Tokyo); 2011 Nov; 13(6):298-300. PubMed ID: 22000064
[TBL] [Abstract][Full Text] [Related]
20. Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy.
Chelko SP; Keceli G; Carpi A; Doti N; Agrimi J; Asimaki A; Beti CB; Miyamoto M; Amat-Codina N; Bedja D; Wei AC; Murray B; Tichnell C; Kwon C; Calkins H; James CA; O'Rourke B; Halushka MK; Melloni E; Saffitz JE; Judge DP; Ruvo M; Kitsis RN; Andersen P; Di Lisa F; Paolocci N
Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
